Clinical Trials

Showing trials with last updates posted in 2021.

NCT02489123 | TERMINATED | PHASE2
8 participants

Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-10
Start Date:
2015-08-11
Completion:
2020-06-16
Conditions
  • Ann Arbor Stage I Mantle Cell Lymphoma
  • Ann Arbor Stage II Mantle Cell Lymphoma
  • Ann Arbor Stage III Mantle Cell Lymphoma
  • Ann Arbor Stage IV Mantle Cell Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page